Leukotrienes in Innate Immunity: Still Underappreciated after All These Years?

J Immunol. 2023 Feb 1;210(3):221-227. doi: 10.4049/jimmunol.2200599.

Abstract

Leukotrienes (LTs) are lipid mediators derived from the 5-lipoxygenase pathway of arachidonate metabolism. Though best known for their role in asthma, they have broad actions that touch on virtually every aspect of mammalian biology. In a Brief Review published in the journal in 2005, we presented the existing evidence supporting a role for LTs in host defense. In this updated Brief Review, we focus on selected advances since then. We detail new insights into mechanisms and regulation of LT biosynthesis; the protective roles of LTs in the host response to diverse classes of pathogens, with an emphasis on viruses, including SARS-CoV-2; the phagocyte signal transduction mechanisms by which LTs exert their antimicrobial actions; the capacity for overexuberant LT production to promote tissue damage; and roles of LTs in the noninfectious immune-relevant conditions neuroinflammation and cancer.

Publication types

  • Review
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arachidonate 5-Lipoxygenase / metabolism
  • COVID-19*
  • Eicosanoids
  • Humans
  • Immunity, Innate
  • Leukotrienes
  • Mammals / metabolism
  • SARS-CoV-2 / metabolism

Substances

  • Arachidonate 5-Lipoxygenase
  • Eicosanoids
  • Leukotrienes